EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 1.560
-0.075 (-4.59%)
Feb 19, 2026, 3:59 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 73.39 million as of February 18, 2026. Its market cap has decreased by -17.25% in one year.
Market Cap
73.39M
Enterprise Value
51.95M
Revenue
66.87M
Ranking
n/a
PE Ratio
10.72
Stock Price
1.56
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has increased from 48.72M to 73.39M, an increase of 50.63%. That is a compound annual growth rate of 8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 76.92M | 15.96% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | 48.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 102.44M |
| LTR Pharma | 94.52M |
| Cynata Therapeutics | 90.66M |
| Alterity Therapeutics | 87.00M |
| Imugene | 80.38M |
| Radiopharm Theranostics | 77.97M |
| Neurizon Therapeutics | 67.49M |
| Prescient Therapeutics | 67.30M |